| 
						
						
						 Return 
						of French farmer's case keeps Monsanto in legal 
						spotlight 
   Send a link to a friend 
		[February 07, 2019]  
		By Catherine Lagrange
 LYON, France (Reuters) - A decade-old 
		lawsuit in which a French farmer with neurological problems accuses 
		Monsanto of not providing adequate safety warnings for a weedkiller 
		returns to court on Wednesday, adding to health claims faced by the 
		Bayer-owned firm.
 | 
        
            | 
			
			 Paul Francois, who says he fell ill after inhaling vapor from 
			weedkiller Lasso in 2004, won rulings in 2012 and 2015 that found 
			Monsanto liable for the intoxication, before France's top court 
			overturned those decisions and ordered a new hearing. 
 An appeal court in the southeastern French city of Lyon will hear 
			arguments on Wednesday before giving its verdict at a later date.
 
 Francois, who says he has suffered memory loss, headaches and 
			stammering, blames Monsanto for not giving sufficient warnings on 
			the product label.
 
 "Maybe we'll lose against Monsanto but the real victory for me is 
			that I have converted my 200-hectare farm to organic production," 
			55-year-old Francois told reporters before the hearing.
 
			
			 
			
 "This affair made me open my eyes and move towards a different kind 
			of agriculture."
 
 Lasso was banned in France in 2007 after the product had already 
			been withdrawn in some other countries.
 
 Bayer said it did not wish to comment specifically on the case until 
			the ruling in the latest proceedings.
 
 But it added in an emailed statement that "the use of phytosanitary 
			products does not pose any risk for human health when they are used 
			according to the terms defined as part of the product 
			authorization."
 
 Monsanto, acquired by Bayer last year, is also facing lawsuits in 
			the United States over alleged cancer links to glyphosate-based 
			weedkillers. Lasso used a different active substance to glyphosate.
 
			
            [to top of second column] | 
 
			Last year, the company was found to be liable for the terminal 
			cancer of a school groundskeeper who had used glyphosate-based 
			products. 
			It is appealing that verdict but faces another U.S. trial next month 
			relating to a couple suffering from cancer.
 In France, a court last month banned a version of Monsanto's Roundup 
			weedkiller range on safety concerns.
 
 Controversy over glyphosate has been fueled by a 2015 conclusion 
			from the World Health Organisation's cancer agency that the 
			substance was probably carcinogenic.
 
 Glyphosate was originally developed by Monsanto but it is off-patent 
			and marketed worldwide by dozens of other crop chemical makers.
 
 After a heated European Union debate in 2017 that led to a five-year 
			renewal for glyphosate's license, President Emmanuel Macron said 
			France would aim to phase out the weedkiller in three years.
 
 (Reporting by Catherine Lagrange in Lyon, additional reporting by 
			Sybille de La Hamaide in Paris, writing by Gus Trompiz; editing by 
			David Evans)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			
			 |